# 15th Annual NIH CounterACT Network Research Symposium

> **NIH NIH U54** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2020 · $150,000

## Abstract

Project Summary/Abstract
The ultimate goal of the 15th Annual CounterACT Network Research Symposium, to be held
at the Higgins Hotel in New Orleans, LA on Tuesday, June 22, 2021 – Thursday, June 24,
2021, is to disseminate knowledge to foster and support research and development of new
and improved therapeutics for chemical threats to the CounterACT Program's grantees
and partners. Chemical threats are toxic chemicals that could be used in a terrorist attack or
accidentally released from industrial production, storage, or shipping. They include traditional
warfare agents, toxic industrial chemicals, and pesticides. The 15th Annual CounterACT Network
Research Symposium (symposium) will facilitate interaction of a national audience of CounterACT
scientists, clinicians, and other early stage investigators and post-doctorial researchers
representing academic institutions, industry and government. This symposium will align with the
CounterACT Programs purpose to support basic and translational research aimed at the
identification of better therapeutic medical countermeasures against chemical threat agents, and
facilitates their movement through the drug development and regulatory processes in
collaboration with other federal departments, agencies, and initiatives. The symposium agenda
will be formatted with educational and networking opportunities to encourage CounterACT
Program grantees, scientists, and mentees to learn from each other to advance the field. The
symposium will be conducted over a 2.5-day period and the agenda will be arranged and
formatted the same as past symposiums and in coordination with NIH CounterACT Program
leadership. The symposium will include highlights from CounterACT Program grantees and will
include a number of keynote presentations, continuing educational sessions, and breakout
sessions that will span the topical areas of Respiratory, Neurological, Dermal, Ocular, and
Metabolic agents. In addition, time on the agenda will be available for presentations by the U54
Centers of Excellence, for rapid presentations by doctoral and post-doctoral mentees working
with CounterACT projects, and for multiple poster session blocks. This symposium is highly
significant because it will give CounterACT Centers of Excellence, grantees, and others
working in the field a platform to disseminate and present cutting-edge research with the
latest technological advances in science and medicine for a more rapid and effective
response during chemical emergencies.

## Key facts

- **NIH application ID:** 10130163
- **Project number:** 3U54ES030246-03S1
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** Mohammad Athar
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $150,000
- **Award type:** 3
- **Project period:** 2018-09-08 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10130163

## Citation

> US National Institutes of Health, RePORTER application 10130163, 15th Annual NIH CounterACT Network Research Symposium (3U54ES030246-03S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10130163. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*